Free Trial

Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume

Lyra Therapeutics logo
$6.92 -0.55 (-7.36%)
Closing price 03:59 PM Eastern
Extended Trading
$6.98 +0.05 (+0.79%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics Short Interest Data

Lyra Therapeutics (LYRA) has a short interest of 45,600 shares, representing 2.95% of the float (the number of shares available for trading by the public). This marks a -8.62% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 21,559 shares to cover all short positions.

Current Short Interest
45,600 shares
Previous Short Interest
49,900 shares
Change Vs. Previous Month
-8.62%
Dollar Volume Sold Short
$305.52 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
1,640,000 shares
Short Percent of Float
2.95%
Today's Trading Volume
15,282 shares
Average Trading Volume
21,559 shares
Today's Volume Vs. Average
71%
Short Selling Lyra Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LYRA Short Interest Over Time

LYRA Days to Cover Over Time

LYRA Percentage of Float Shorted Over Time

Lyra Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202545,600 shares $305.52 thousand -8.6%2.9%0.1 $6.70
7/15/202549,900 shares $423.15 thousand -59.7%N/A0.1 $8.48
6/30/2025123,900 shares $1.11 million +8.9%7.7%0.2 $8.96
6/15/2025113,800 shares $1.29 million +37.9%8.6%0.2 $11.34
5/31/202582,500 shares $386.10 thousand -43.7%7.4%0.1 $4.68
5/15/2025146,600 shares $16.54 thousand -94.6%13.1%2.3 $0.11
4/30/20252,700,000 shares $320.76 thousand +21.6%N/A1.5 $0.12
4/15/20252,220,000 shares $204.68 thousand -7.9%3.6%1.9 $0.09
3/31/20252,410,000 shares $304.38 thousand +0.4%3.9%2.2 $0.13
3/15/20252,400,000 shares $412.80 thousand +27.7%3.8%2 $0.17
2/28/20251,880,000 shares $402.32 thousand -13.4%3.0%1.5 $0.21
2/15/20252,170,000 shares $451.79 thousand +1.4%3.5%1.5 $0.21
1/31/20252,140,000 shares $391.19 thousand +0.5%N/A1.2 $0.18
1/15/20252,130,000 shares $402.57 thousand +1.4%N/A1.1 $0.19
12/31/20242,100,000 shares $433.44 thousand +14.1%N/A1.1 $0.21
12/15/20241,840,000 shares $335.98 thousand -16.4%N/A1.1 $0.18
11/30/20242,200,000 shares $455.40 thousand -7.6%N/A1.4 $0.21
11/15/20242,380,000 shares $404.60 thousand +16.7%N/A1.6 $0.17
10/31/20242,040,000 shares $560.80 thousand -4.7%N/A2.1 $0.27
10/15/20242,140,000 shares $488.78 thousand -24.9%N/A2.2 $0.23
9/30/20242,850,000 shares $732.45 thousand -9.2%N/A3.2 $0.26
9/15/20243,140,000 shares $879.20 thousand +6.1%N/A2.7 $0.28
8/31/20242,960,000 shares $952.23 thousand -28.7%N/A2.3 $0.32
8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29
7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33
7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31
6/30/20241,990,000 shares $550.63 thousand +28.4%N/A0.5 $0.28
6/15/20241,550,000 shares $457.56 thousand +71.8%N/A0.4 $0.30
5/31/2024902,200 shares $295.92 thousand +49.6%N/A0.3 $0.33
5/15/2024603,000 shares $214.55 thousand +45.7%N/A0.2 $0.36
4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16
4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27
3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22
3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93
2/29/2024160,200 shares $842.65 thousand -13.6%N/A0.6 $5.26
2/15/2024185,400 shares $927 thousand +43.5%N/A0.8 $5.00
1/31/2024129,200 shares $587.86 thousand -5.6%N/A0.6 $4.55
1/15/2024136,900 shares $736.52 thousand -22.6%N/A0.6 $5.38
12/31/2023176,800 shares $926.43 thousand +2.4%N/A0.9 $5.24
12/15/2023172,600 shares $802.59 thousand -24.4%N/A0.7 $4.65
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
11/30/2023228,300 shares $755.67 thousand -13.9%N/A0.6 $3.31
11/15/2023265,200 shares $766.43 thousand -17.3%N/A0.7 $2.89
10/31/2023320,600 shares $952.18 thousand +43.2%N/A0.9 $2.97
10/15/2023223,900 shares $801.56 thousand -38.2%N/A0.6 $3.58
9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91
9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35
8/31/202355,300 shares $192.44 thousand -19.5%N/A0.3 $3.48
8/15/202368,700 shares $245.95 thousand -67.0%N/A0.4 $3.58
7/31/2023208,100 shares $670.08 thousand -62.3%N/A1.1 $3.22
7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06
6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11
6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99
5/31/2023285,500 shares $733.74 thousand +1,513.0%N/A3.7 $2.57
5/15/202317,700 shares $46.20 thousand -31.4%N/A0.5 $2.61
4/30/202325,800 shares $61.92 thousand +27.1%N/A0.7 $2.40
4/15/202320,300 shares $48.52 thousand +178.1%N/A0.6 $2.39
3/31/20237,300 shares $14.67 thousand -29.1%N/A0.2 $2.01
3/15/202310,300 shares $21.01 thousand -32.2%N/A0.3 $2.04
2/28/202315,200 shares $36.18 thousand +22.6%N/A0.5 $2.38
2/15/202312,400 shares $30.26 thousand +21.6%N/A0.4 $2.44
1/31/202310,200 shares $29.07 thousand -21.5%N/A0.3 $2.85
1/15/202313,000 shares $36.01 thousand -29.7%N/A0.2 $2.77
12/30/202218,500 shares $58.09 thousand +44.5%N/A0.3 $3.14
12/15/202212,800 shares $34.94 thousand -41.6%N/A0.2 $2.73
11/30/202221,900 shares $76.87 thousand +0.5%N/A0.3 $3.51
11/15/202221,800 shares $85.02 thousand No ChangeN/A0.3 $3.90
10/31/202221,800 shares $102.24 thousand -27.6%N/A0.3 $4.69
10/15/202230,100 shares $144.48 thousand -16.4%N/A0.9 $4.80
9/30/202236,000 shares $180.36 thousand -45.4%N/A1 $5.01
9/15/202265,900 shares $392.76 thousand -25.5%N/A1.6 $5.96
8/31/202288,400 shares $511.84 thousand -18.8%N/A1.4 $5.79
8/15/2022108,800 shares $683.26 thousand -22.6%N/A1.6 $6.28
7/31/2022140,600 shares $912.49 thousand -44.2%N/A1.9 $6.49
7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69
6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65
6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02
5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35
5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88
4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65
4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51
3/31/202277,200 shares $310.34 thousand +19.0%0.9%0.5 $4.02
3/15/202264,900 shares $262.85 thousand -44.8%0.7%1.5 $4.05
2/28/2022117,500 shares $572.23 thousand +36.3%1.2%2.4 $4.87
2/15/202286,200 shares $387.90 thousand +9.1%0.9%1.6 $4.50
1/31/202279,000 shares $323.11 thousand +5.6%0.8%1.3 $4.09
1/15/202274,800 shares $295.46 thousand +4.0%0.8%1.2 $3.95
12/31/202171,900 shares $313.48 thousand -5.8%0.8%1.2 $4.36
12/15/202176,300 shares $334.19 thousand -1.0%0.8%1.4 $4.38
11/30/202177,100 shares $431.76 thousand +2.5%0.8%1.4 $5.60
11/15/202175,200 shares $539.94 thousand -51.4%0.9%1.5 $7.18
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30
10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85
9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12
9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28
8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14
8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94
7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44
7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45
6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03
6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17
5/28/2021358,900 shares $2.58 million -13.2%4.1%3.4 $7.18
5/14/2021413,600 shares $3.09 million +14.1%4.8%4.6 $7.46
4/30/2021362,500 shares $3.69 million +10.9%4.4%2.4 $10.18
4/15/2021327,000 shares $3.56 million +4.1%3.9%2.1 $10.89
3/31/2021314,200 shares $3.51 million +11.3%3.8%2.1 $11.17
3/15/2021282,300 shares $3.95 million +15.4%3.4%1.8 $13.98
2/26/2021244,600 shares $3.42 million +73.6%3.1%1.3 $14.00
2/12/2021140,900 shares $1.86 million -1.4%1.8%0.7 $13.19
1/29/2021142,900 shares $1.53 million +9.3%1.8%1.1 $10.68
1/15/2021130,800 shares $1.43 million No Change1.6%1.1 $10.96

LYRA Short Interest - Frequently Asked Questions

What is Lyra Therapeutics' current short interest?

Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 45,600 shares of LYRA short. 2.95% of Lyra Therapeutics' shares are currently sold short. Learn More on Lyra Therapeutics' current short interest.

What is a good short interest percentage for Lyra Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.95% of Lyra Therapeutics' floating shares are currently sold short.

Is Lyra Therapeutics' short interest increasing or decreasing?

Lyra Therapeutics saw a decrease in short interest in July. As of July 31st, there was short interest totaling 45,600 shares, a decrease of 8.6% from the previous total of 49,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Lyra Therapeutics' short interest compare to its competitors?

2.95% of Lyra Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: Zynex Inc. (19.33%), Nephros Inc. (0.05%), SurgePays, Inc. (1.05%), NeuroOne Medical Technologies Corporation (0.34%), Vicarious Surgical Inc. (2.55%), electroCore, Inc. (7.83%), Modular Medical, Inc. (0.33%), Plus Therapeutics, Inc. (3.10%), Precision Optics Corp. (1.19%), CollPlant Biotechnologies Ltd. Sponsored ADR (1.09%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Lyra Therapeutics stock?

Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lyra Therapeutics?

A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further.

How often is Lyra Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:LYRA) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners